The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations

Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis

(2018) Mathias Granqvist et al.   JAMA Neurology

Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’)

(2017) Jaran Eriksen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

(2017) Irene Eriksson et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Update on disease-modifying therapies for multiple sclerosis

(2017) Diana L Vargas et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

(2016) Peter Alping et al.   ANNALS OF NEUROLOGY

Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis

(2016) Joris Komen et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Rituximab for treating multiple sclerosis

(2016) Dennis Bourdette   NEUROLOGY

Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations

(2015) Racquel Jandoc et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Swedish general practitioners’ attitudes towards treatment guidelines – a qualitative study

(2014) Veronica Milos et al.   BMC Family Practice

Factors affecting the uptake of new medicines: a systematic literature review

(2014) Ágnes Lublóy   BMC HEALTH SERVICES RESEARCH

In the coming year we should abandon interferons and glatiramer acetate as first-line therapy for MS: Yes

(2013) Robert J Fox   Multiple Sclerosis Journal

Interferon Beta and Glatiramer Acetate Therapy

(2012) Corey A. McGraw et al.   Neurotherapeutics

New medicines in primary care: a review of influences on general practitioner prescribing

(2010) A. Mason   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Factors affecting the uptake of new medicines in secondary care a literature review

(2008) D. Chauhan et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS